Navigation Links
OmniComm Ranks Number 220 on Deloitte's 2010 Technology Fast 500 for Fastest Growing Companies in North America

FORT LAUDERDALE, Fla., Oct. 22 /PRNewswire/ -- OmniComm Systems, Inc (OTC: OMCM.OB) today announced that it ranked number 220 on Technology Fast 500, Deloitte LLP's ranking of 500 of the fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Rankings are based on the percentage of fiscal year revenue growth during the period from 2005-2009. OmniComm grew 445 percent during this period.

OmniComm's CEO, Cornelis F. Wit, credits the expansion of its customer base in the US and Europe and the addition of its new product lines with the company's 445% revenue growth. "We are very pleased to be ranked on the Technology Fast 500 list for the third time in the last 5 years," said Mr. Wit.  "Our growth has been steady with our existing EDC product line and the addition of our new eClinical product lines- including TrialOne for phase I automation and CDMS, CTMS, and Safety solutions have allowed us to enter into new markets."

"OmniComm and the other 2010 Technology Fast 500 winners forged ahead in a challenging economic environment to realize exceptional growth," said Phil Asmundson, vice chairman and Deloitte's U.S. technology, media and telecommunications leader. "Deloitte commends OmniComm for this impressive accomplishment."

"OmniComm has proved itself to be one of the fastest growing tech companies in North America, and we are proud to honor them as one of the 2010 Technology Fast 500," said Mark Jensen, managing partner, venture capital services, Deloitte & Touche LLP.

OmniComm previously ranked #284 as a Technology Fast 500 award winner in 2009, and earlier in 2005 as #140. Overall, Technology Fast 500 award winners for 2010 had revenue growth ranging from 146 percent to 164,709 percent from 2005 to 2009, with an average growth of 2,361 percent.

For additional detail on the Technology Fast 500 including selection and qualifying criteria, visit

About OmniComm

OmniComm Systems, Inc ( provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver specific products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's client intuitive pricing model allows companies that range from small, to mid-size to large scale institutions to safely and efficiently capitalize on their clinical research investments. OmniComm Systems, Inc has a U.S. Headquarters in Fort Lauderdale, FL. and European headquarters in Bonn, Germany, with satellite offices in New Jersey, and the United Kingdom. There are sales offices throughout the U.S. and Europe.

About Deloitte

As used in this document, "Deloitte" means Deloitte LLP. Please see for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.

Safe Harbor Disclaimer

Safe Harbor Disclaimer Statements made by OmniComm included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Such statements involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertainty regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand.  As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission.  The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

CONTACT: Stephen Johnson at + 1 954-377-1726

SOURCE OmniComm Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. OmniComm Systems, Inc. Is Fueled by Another Strong Quarter Delivering Electronic Data Capture (EDC) Solutions & Services
2. OmniComm Systems, Inc. Experiences Record Year End Results - $18 Million in Signed Contracts for the Year 2008
3. OmniComm Systems Announces Settlement of Patent Litigation With DataSci, LLC
4. OmniComm Systems Announces 1st Quarter Results of Operations
5. OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President, Europe & Asia/Pacific
6. OmniComm Systems Announces Acquisition of EDC Business of eResearchTechnology
7. Growing Midwestern Clinical Research Organization Selects OmniComm Systems to Provide eClinical Solutions for Phase IV Studies
8. OmniComm Systems Acquires EDC Assets of Leading Phase I Clinical Software Vendor - Logos Technologies, Ltd.
9. Leading European Contract Research Organization Selects OmniComm to Provide eClinical Solutions for Important Phase III Study
10. OmniComm Systems Inc. Expands Its Successful CRO Preferred Program(TM) By Signing On Three New CRO Partners
11. MicroTech Ranks No. 285 on Inc. Magazines 2008 List of the 500 Fastest Growing Private Companies in America
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... Conference in New York on Wednesday, December ... Helen Torley , president and CEO, will provide a corporate overview. ... New York at 1:00 p.m. ET/10:00 a.m. PT . ... investor relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the "Company"), ... Toronto Stock Exchange, confirms that as of the date ... that would cause the recent movements in the Company,s ... About Aeterna Zentaris Inc. . ... Zentaris is a specialty biopharmaceutical company engaged in developing ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... The Academy ... Special Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent the ... last few years. Many AMA members have embraced this type of racing and several ...
Breaking Biology Technology:
(Date:10/26/2015)... India , October 26, 2015 ... --> adds ... 2015 to 2021 as well as ... 2015-2019 research reports to its collection ... . --> ...
(Date:10/23/2015)... -- Research and Markets ( ) has announced ... Market 2015-2019" report to their offering. ... voice recognition biometrics market to grow at a CAGR ... --> The report, Global Voice Recognition ... in-depth market analysis with inputs from industry experts. The ...
(Date:10/22/2015)... Oct. 22, 2015  Synaptics (NASDAQ: SYNA ), a leading ... first quarter ended September 30, 2015. --> ... fiscal 2016 grew 66 percent over the comparable quarter last year ... 2016 was $23.8 million, or $0.62 per diluted share. ... the first quarter of fiscal 2016 grew 39 percent over the ...
Breaking Biology News(10 mins):